ライフサイエンスコーパス: mortality decline

1 nfarction, which may have contributed to the mortality decline.

2 condary diagnosis of pneumonia increased and mortality declined.

3 5% in 1991 through 1995, P < .05), operative mortality declined (13% in 1966 through 1985; 0% in 1991

4 Age-adjusted heart disease mortality declined 27% in nondiabetic women but increase

5 (40.1% vs. 71.9%; P < 0.0001), and hospital mortality declined (38.1% vs. 14.7%; P < 0.0001).

6 CLD mortality declined 5% overall from 1990 through 1994 (12

7 Cardiovascular disease mortality declined 59% between the female cohorts and 53

8 After multivariable adjustment, odds of mortality declined 61% by the year 2009.

9 past reproductive age, and why does juvenile mortality decline after birth, both contrary to the clas

10 Mortality declines aggregated across all age groups mask

11 nning of HIV treatment scale-up in 2004, HIV mortality declined among both men and women.

12 e found that from 2000 through 2011, overall mortality declined among extremely premature infants.

13 en and men, the HR of cardiovascular disease mortality declined among those with and without diabetes

14 Non-cardiovascular disease mortality declined among women without diabetes mellitus

15 NADCs will likely grow in importance as AIDS mortality declines and PWHIV age.

16 a constraint on any theory of society-driven mortality decline, and provides a basis for stochastic m

17 he poor understanding of the factors driving mortality decline, and the difficulty of forecasting mor

18 > or =11 and < or =12, and >12 g/dl, risk of mortality declined as Hb level increased.

19 ing the first decade of the 21st century, HD mortality declined at a much greater rate than cancer mo

20 After outlier designation, in-hospital mortality declined at outlier institutions to a greater

21 neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000

22 Direct obstetric mortality declined by 3% per year (rate ratio 0.97 per y

23 .1 percent per year, whereas out-of-hospital mortality declined by 3.6 percent per year.

24 Maternal mortality declined by 8.9% per year between 1997 and 201

25 From 1966 to 1982, the mortality declined by an average of 13.0 percent annuall

26 The biggest contributions to the CHD mortality decline came from secular decreases in blood p

27 , and 31.0%; P=0.003 for trend, but adjusted mortality declined (compared with 1992-1993, relative ri

28 Adjusted rates of hospitalization and mortality declined consistently in the subgroup with a p

29 ce 1969 is due to the faster pace of old-age mortality decline during recent decades.

30 ter <or=10 microm in aerodynamic diameter on mortality declined during 1987-2000 and that this declin

31 Mortality declined during that time but remained >50% du

32 Infectious disease mortality declined during the first 8 decades of the 20t

33 Operative mortality declined during the study period for both inta

34 unted for approximately 52% (40%-70%) of the mortality decline, equitably distributed across all soci

35 In-hospital mortality declined faster than out-of-hospital mortality

36 From 1970 to 1994, varicella mortality declined, followed by an increase.

37 Operative mortality declined for all eight procedures, ranging fro

38 After 1994, calendar period mortality declined for both.

39 The female-to-male rate ratio for HIV mortality declined from 0.93 (95% CI 0.82-1.07) in 2003

40 For women, HIV mortality declined from 1.60 deaths per 100 person-years

41 For men, HIV-related mortality declined from 1.71 per 100 person-years (95% C

42 stay fell from 8.3 to 4.3 days, and hospital mortality declined from 11.2% to 9.4% (both p = 0.0001).

43 Between 1980 to 1989 and 2000 to 2009, MI mortality declined from 12.5% to 3.2% within 30 days, 5.

44 0 and 2002 (P = .005), and treatment-related mortality declined from 19% to 12% (P = .025).

45 Mortality declined from 21.7% in 2004 to 9.7% in 2010 am

46 ncreased 9.3% from 0.44 to 0.48 per 1000 and mortality declined from 25.1% to 19.2% (ARR, 6.0%; 95% C

47 Mortality declined from 44.7 to 27.1 (P<0.0001) for thos

48 Mortality declined from 5.3 percent in 1996 to 2.1 perce

49 nomous region during the same period, infant mortality declined from 64 to 59 per 1000 and under-5 mo

50 Kaplan-Meier estimates of 6-month mortality declined from 7.0% [95% confidence interval 6.

51 The mortality decline in the USA was greatest and most susta

52 8.7 to 29.3) from 1990 to 2015, the rates of mortality decline in this period substantially varied ac

53 ed with increased mortality in group II, but mortality declined in group III despite the continued in

54 Mortality declined in patients with AIDS (39% in 1999 to

55 ociated with the risk of COPD exacerbations, mortality, decline in FEV1, and response to both inhaled

56 creased in Romania and Japan; therefore, the mortality decline is not universal.

57 omania, Austria, and Denmark; therefore, the mortality decline is not universal.

58 Over the past 25 years, CVD mortality declined markedly in the community, but there

59 Between 2004 and 2008, all-cause adult mortality declined more in PEPFAR focus countries relati

60 urred in the 1-59 months age group; neonatal mortality declined more slowly (from 50 to 23 deaths per

61 The most rapid mortality decline occurred in the 1-59 months age group;

62 The largest mortality declines occurred between the 1950 and 1960 fe

63 Mortality declines of the early 1990s were not sustained

64 t when a population has experienced a smooth mortality decline or only short periods of excess mortal

65 ulations that have experienced either smooth mortality declines or only short periods of excess morta

66 Wait-list mortality declined over the past decade, including among

67 15 developed countries shows that, as infant mortality declined over two centuries, the excess male m

68 Cancer mortality declined overall in the United States between

69 While acute myocardial infarction mortality declines, patients continue to face reinfarcti

70 However, observed in-hospital mortality declined significantly for women from 2001 to

71 creased slightly over time, observed 6-month mortality declined significantly in all age strata (1994

72 emiology, the incidence of MI and associated mortality declined significantly in all US Census Divisi

73 Although mortality declined significantly in recent years, novel

74 Heart disease mortality declined significantly in whites (237 to 216 p

75 Risk-adjusted in-hospital mortality declined slightly in the overall cohort from 9

76 Between 1988 and 2002, in-hospital mortality declined steadily in patients with ARF (40.4 t

77 While HAV-related mortality declined, the mean age at death among decedent

78 itical care advances and intensive care unit mortality declines, the number of survivors of critical

79 For blacks, calendar period mortality declined until the late 1970s, and then sharpl

80 In the US population, no acceleration of mortality decline was observed in either ACVD or CAD mor

81 Adults >/=65 years of age showed consistent mortality declines, which became even steeper after 2000

82 ssociation of a breast cancer diagnosis with mortality declined with age among women with advanced di

83 Associations between income inequality and mortality declined with age at death, and then reversed

84 AIDS-related mortality declined with increasing CD4:CD8 ratio and dec

85 ith severe sepsis, although its influence on mortality declined with time.

86 g postreproductive survival and why juvenile mortality declines with age.

87 was used to determine whether divergence of mortality declines would be expected under an assumption